Loading company…
Tetra Pharm Technologies develops cannabinoid-based therapies and provides pharmaceutical manufacturing services.
Founded in 2018, Tetra Pharm Technologies develops cannabinoid-based therapies, conducts drug research and clinical studies, and provides GMP manufacturing and CDMO services. The company is based in Copenhagen, Denmark. It raised EUR 9 million in Series A funding in January 2023 from Enexis AB, Leafy Tunnel, Nesroht Holding, Ole GS Holding, and Rump Invest.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in